Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Matthias Waldner
New Perspectives on mTOR Inhibitors (Rapamycin, Rapalogs and TORKinibs) in Transplantation
British Journal of Clinical Pharmacology
Pharmacology
Related publications
Rapalogs and mTOR Inhibitors as Anti-Aging Therapeutics
Journal of Clinical Investigation
Medicine
New Perspectives on the Use of mTOR Inhibitors in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-Versus-Host Disease
British Journal of Clinical Pharmacology
Pharmacology
Transplantation: Are Calcineurin Inhibitors Safer Than mTOR Inhibitors?
Nature Reviews Nephrology
Nephrology
Conversion From Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplantation: A Single Centre Experience
Turkish Nephrology, Dialysis and Transplantation Journal
Surgery
Urology
GOLPH3 Modulates mTOR Signalling and Rapamycin Sensitivity in Cancer
Nature
Multidisciplinary
New Targets for Therapy in Breast Cancer: Mammalian Target of Rapamycin (mTOR) Antagonists
Breast Cancer Research
Cancer Research
Oncology
Impact on Autophagy and Ultraviolet B Induced Responses of Treatment With the MTOR Inhibitors Rapamycin, Everolimus, Torin 1, and Pp242 in Human Keratinocytes
Oxidative Medicine and Cellular Longevity
Biochemistry
Medicine
Cell Biology
Aging
Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)
Science-Business eXchange
Letter: Mechanistic Target of Rapamycin Inhibitors-Do They Impact on Recurrence of Hepatocellular Carcinoma After Liver Transplantation?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
